IOL Chemicals and Pharmaceuticals Limited Total Assets
IOL Chemicals and Pharmaceuticals Limited total assets. Based on the latest financial reports, IOL Chemicals and Pharmaceuticals Limited (IOLCP) holds total assets worth Rs25.87 Billion INR (≈ $279.77 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see IOLCP operating cash flow for how efficiently the company converts equity into cash flow.
Total Assets of IOL Chemicals and Pharmaceuticals Limited (2005–2026)
Total assets of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026. This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. See IOL Chemicals and Pharmaceuticals Limite stock quote for real-time trading data and today's change.
IOL Chemicals and Pharmaceuticals Limited - Asset Composition Analysis
IOL Chemicals and Pharmaceuticals Limited Total Assets Breakdown (March 2026)
IOL Chemicals and Pharmaceuticals Limited total assets breakdown as of March 2026. IOL Chemicals and Pharmaceuticals Limited's total assets of Rs25.87 Billion consist of 47.5% current assets and 52.6% non-current assets. Explore IOLCP net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 7.7% |
| Accounts Receivable | Rs6.03 Billion | 23.3% |
| Inventory | Rs3.71 Billion | 14.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs147.10 Million | 0.6% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2005–2026)
This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: IOL Chemicals and Pharmaceuticals Limited's current assets represent 47.5% of total assets in 2026, an increase from 41.7% in 2005.
- Cash Position: Cash and equivalents constituted 7.7% of total assets in 2026, up from 0.3% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 23.3% of total assets.
IOL Chemicals and Pharmaceuticals Limited Competitors by Total Assets
Key competitors of IOL Chemicals and Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
|
Zhejiang Medicine Co Ltd
SHG:600216
|
China | CN¥14.18 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
|
Dezhan HealthCare Co Ltd
SHE:000813
|
China | CN¥4.77 Billion |
|
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907
|
China | CN¥2.00 Billion |
IOL Chemicals and Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.78 | 1.89 | 3.52 |
| Quick Ratio | 1.24 | 1.30 | 2.50 |
| Cash Ratio | 0.00 | 0.34 | 0.00 |
| Working Capital | Rs5.37 Billion | Rs5.41 Billion | Rs7.32 Billion |
IOL Chemicals and Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between IOL Chemicals and Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 8.6% |
| Total Assets | Rs25.87 Billion |
| Market Capitalization | $587.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values IOL Chemicals and Pharmaceuticals Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: IOL Chemicals and Pharmaceuticals Limited's assets grew by 8.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for IOL Chemicals and Pharmaceuticals Limited (2005–2026)
The table below shows the annual total assets of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs25.87 Billion ≈ $279.77 Million |
+8.60% |
| 2025-03-31 | Rs23.82 Billion ≈ $257.61 Million |
+6.13% |
| 2024-03-31 | Rs22.44 Billion ≈ $242.72 Million |
+10.99% |
| 2023-03-31 | Rs20.22 Billion ≈ $218.69 Million |
+3.05% |
| 2022-03-31 | Rs19.62 Billion ≈ $212.22 Million |
+21.88% |
| 2021-03-31 | Rs16.10 Billion ≈ $174.13 Million |
+37.64% |
| 2020-03-31 | Rs11.70 Billion ≈ $126.51 Million |
+24.20% |
| 2019-03-31 | Rs9.42 Billion ≈ $101.86 Million |
+10.54% |
| 2018-03-31 | Rs8.52 Billion ≈ $92.15 Million |
+4.23% |
| 2017-03-31 | Rs8.17 Billion ≈ $88.41 Million |
+5.36% |
| 2016-03-31 | Rs7.76 Billion ≈ $83.91 Million |
+10.58% |
| 2015-03-31 | Rs7.02 Billion ≈ $75.88 Million |
-5.33% |
| 2014-03-31 | Rs7.41 Billion ≈ $80.15 Million |
+1.95% |
| 2013-03-31 | Rs7.27 Billion ≈ $78.62 Million |
+5.82% |
| 2012-03-31 | Rs6.87 Billion ≈ $74.29 Million |
+12.64% |
| 2011-03-31 | Rs6.10 Billion ≈ $65.95 Million |
+20.00% |
| 2010-03-31 | Rs5.08 Billion ≈ $54.96 Million |
+21.08% |
| 2009-03-31 | Rs4.20 Billion ≈ $45.39 Million |
+73.96% |
| 2008-03-31 | Rs2.41 Billion ≈ $26.09 Million |
+36.49% |
| 2007-03-31 | Rs1.77 Billion ≈ $19.12 Million |
+86.77% |
| 2006-03-31 | Rs946.52 Million ≈ $10.24 Million |
+57.54% |
| 2005-03-31 | Rs600.82 Million ≈ $6.50 Million |
-- |
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more